COO (The Cooper) ROIC %: -1.04% (As of Apr. 2026)


COO The Cooper Companies Inc COO
85 GF Score
Price $68.83
GF Value $100.85
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper ROIC %?

The Cooper COO +4.04% 85 ROIC % is -1.04% as of Apr. 2026. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.85 (Significantly Undervalued). The stock has 3 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The Cooper's annualized return on invested capital (ROIC %) for the quarter that ended in Apr. 2026 was -1.04%.

As of today (2026-06-24), The Cooper's WACC % is 7.71%. The Cooper's ROIC % is 2.38% (calculated using TTM income statement data). The Cooper earns returns that do not match up to its cost of capital. It will destroy value as it grows.


The Cooper  (NAS:COO) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, The Cooper's WACC % is 7.71%. The Cooper's ROIC % is 2.38% (calculated using TTM income statement data). The Cooper earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


The Cooper ROIC % Related Terms


The Cooper ROIC % Historical Data

* Premium members only.

The historical data trend for The Cooper's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper ROIC % Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.40 4.03 3.39 4.09 3.78

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.74 3.78 3.39 4.82 -1.04

COO vs ALGN, SOLV, BAX: ROIC % Comparison

For the Medical Instruments & Supplies subindustry, The Cooper's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper ROIC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's ROIC % distribution charts can be found below:

* The bar in red indicates where The Cooper's ROIC % falls into.


COO
85GF Score
The Cooper Companies Inc COO
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper ROIC % Calculation

The Cooper's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Oct. 2025 is calculated as:

ROIC % (A: Oct. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Oct. 2024 ) + Invested Capital (A: Oct. 2025 ))/ count )
=682.9 * ( 1 - 33.82% )/( (11947.1 + 11983.8)/ 2 )
=451.94322/11965.45
=3.78 %

where

The Cooper's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Apr. 2026 is calculated as:

ROIC % (Q: Apr. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2026 ) + Invested Capital (Q: Apr. 2026 ))/ count )
=-124 * ( 1 - 0% )/( (12073.5 + 11785.4)/ 2 )
=-124/11929.45
=-1.04 %

where

Note: The Operating Income data used here is four times the quarterly (Apr. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -1.04% mean?
The Cooper (COO) has a ROIC % of -1.04% as of Apr. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on The Cooper and its competitors.
Is The Cooper's ROIC % too high?
The Cooper's current ROIC % is -1.04%. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's ROIC % compare to ALGN and SOLV?
The Cooper's ROIC % of -1.04% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROIC % is 1.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Medical Devices & Instruments company?
The median ROIC % among Medical Devices & Instruments companies is 1.27, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median ROIC % is 1.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current ROIC % is -1.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.85, compared to a current price of $68.83 — trading 31.8% below its estimated fair value. The current ROIC % is -1.04%. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For The Cooper (COO), the current ROIC % is -1.04% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of $68.83 is trading 31.8% below its estimated GF Value™ of $100.85. GuruFocus considers The Cooper to be Significantly Undervalued.

Key valuation signals for COO:

  • ROIC %: -1.04%
  • GF Value™: $100.85 vs. price of $68.83 (31.8% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score

Get the complete analysis for COO

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.83
Price
$100.85
GF Value